- Home
- SEE vs PRCT Comparison
SEE vs PRCT Comparison
Compare SEE & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SEE
- PRCT
- Stock Information
- Founded
- SEE 1960
- PRCT 2009
- Country
- SEE United States
- PRCT United States
- Employees
- SEE N/A
- PRCT N/A
- Industry
- SEE Major Chemicals
- PRCT Medical Specialities
- Sector
- SEE Industrials
- PRCT Health Care
- Exchange
- SEE Nasdaq
- PRCT Nasdaq
- Market Cap
- SEE 5.3B
- PRCT 4.7B
- IPO Year
- SEE N/A
- PRCT 2021
- Fundamental
- Price
- SEE $32.34
- PRCT $62.25
- Analyst Decision
- SEE Buy
- PRCT Strong Buy
- Analyst Count
- SEE 13
- PRCT 7
- Target Price
- SEE $40.00
- PRCT $97.86
- AVG Volume (30 Days)
- SEE 1.2M
- PRCT 764.2K
- Earning Date
- SEE 02-25-2025
- PRCT 02-25-2025
- Dividend Yield
- SEE 2.47%
- PRCT N/A
- EPS Growth
- SEE 26.45
- PRCT N/A
- EPS
- SEE 2.72
- PRCT N/A
- Revenue
- SEE $5,397,300,000.00
- PRCT $199,843,000.00
- Revenue This Year
- SEE N/A
- PRCT $67.07
- Revenue Next Year
- SEE $0.59
- PRCT $40.64
- P/E Ratio
- SEE $11.90
- PRCT N/A
- Revenue Growth
- SEE N/A
- PRCT 71.71
- 52 Week Low
- SEE $30.87
- PRCT $45.20
- 52 Week High
- SEE $41.14
- PRCT $103.81
- Technical
- Relative Strength Index (RSI)
- SEE 30.02
- PRCT 29.56
- Support Level
- SEE $32.95
- PRCT $64.04
- Resistance Level
- SEE $34.67
- PRCT $68.38
- Average True Range (ATR)
- SEE 0.71
- PRCT 3.30
- MACD
- SEE -0.19
- PRCT -0.15
- Stochastic Oscillator
- SEE 1.72
- PRCT 1.14
About SEE Sealed Air Corporation
Sealed Air is organized via two reporting segments. Food care includes food packaging products like Cryovac, Darfresh, and OptiDure aimed primarily at meats. Product care includes Sealed Air's Bubble Wrap, Instapak, Jiffy mailers, and shrink film packaging systems that cater to industrial and e-commerce applications.
About PRCT PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System,, image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. The company's assets are based in the United States. Its revenue is generated from sales of the AquaBeam Robotic System and the accompanying single-use disposable handpieces.